Delivery Order SPE2DB22D2214-SPE2DB25FS6FA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,339.76 for Albuterol HFA 90 mcg inhalers (8.5 gm) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) at a ceiling value of $1,585.92. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a direct procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was applied to this award, indicating it was competitively...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.53 firm fixed price delivery order is for the supply of 4567531714 Albuterol HFA 90 MCG Inhalers 8.5GM. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a firm-fixed-price of $1,997.88 and a period of performance through November 16, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Albuterol HFA 90 microgram inhalers (8.5 grams) with a ceiling value of $1,201.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation and falls under the company's existing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 18GM. The order is a firm fixed-price contract with a ceiling value of $1,029.35 and a completion date of March 28, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6FADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,445.76 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and medical devices across multiple therapeutic domains. The arrangement allows AmerisourceBergen to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism aligned with the DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/19/25 |